{"id":"W4387810265","doi":"10.1016/j.annonc.2023.09.2748","title":"1799P Real-world (RW) treatment (tx) patterns of metastatic prostate cancer (mPCa) with enhanced access to homologous recombination repair (HRR) genomic testing and poly ADP ribose polymerase inhibitor (PARPi)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Baker Hughes (Canada); BC Cancer Agency; University of Alberta; University of Calgary","funders":"Ipsen; Eisai; AstraZeneca; Amgen; Pfizer; Astellas Pharma; F. Hoffmann-La Roche","keywords":"Olaparib; Medicine; Prostate cancer; Internal medicine; Oncology; PARP inhibitor; Docetaxel; Cancer; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001753186,0.0001111548,0.0001269626,0.0002560726,0.0001750862,0.0003861396,0.0002242729,0.0001966559,0.006909663],"category_scores_gemma":[0.0006202366,0.00007237156,0.0001749813,0.0004754379,0.0002617342,0.0002104799,0.0002403828,0.0002705016,0.0007658905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003625992,"about_ca_system_score_gemma":0.0002642457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002912333,"about_ca_topic_score_gemma":0.004937791,"domain_scores_codex":[0.9998417,0.00003258926,0.00001342351,0.00004288993,0.0000420232,0.00002724586],"domain_scores_gemma":[0.9997329,0.00005008185,0.0001082733,0.00003454779,0.00003279309,0.00004133505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006934214,0.0005265363,0.6682525,0.000291053,0.0002748936,0.005654281,0.0003406162,0.007609399,0.0548205,0.002873934,0.01194082,0.2404812],"study_design_scores_gemma":[0.0001410271,0.00220805,0.905493,0.00003711339,0.0001516386,0.01898444,0.0009174448,0.01074512,0.02401195,0.002375621,0.03489841,0.00003613527],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790083,0.0004093861,0.003220907,0.0005757128,0.00003950491,0.00006336571,0.004739088,0.0001309314,0.01181289],"genre_scores_gemma":[0.9960055,0.0000916538,0.000925954,0.00007356153,0.00000631803,0.0000207004,0.001236958,0.00002254498,0.001616756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006909663,"threshold_uncertainty_score":0.02311516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1348306269186467,"score_gpt":0.4325496976513883,"score_spread":0.2977190707327416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}